am 580 and fenretinide

am 580 has been researched along with fenretinide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamo, S; Avvisati, G; Benedetti, L; Diverio, D; Gambacorti-Passerini, C; Grignani, F; Jetten, AM; Levin, AA; Lo Coco, F; Nervi, C; Pelicci, PG; Scicchitano, BM1
Collins, G; Dawson, HD; Key, M; Pyle, R; Taub, DD1

Other Studies

2 other study(ies) available for am 580 and fenretinide

ArticleYear
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
    Blood, 1996, Mar-01, Volume: 87, Issue:5

    Topics: Apoptosis; Benzoates; CD18 Antigens; Cell Differentiation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytosol; Drug Resistance, Neoplasm; Enzyme Induction; Fenretinide; Gene Expression Regulation, Leukemic; Humans; Isoenzymes; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Protein Multimerization; Receptors, Retinoic Acid; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Transglutaminases; Translocation, Genetic; Tretinoin; Tumor Cells, Cultured

1996
The Retinoic Acid Receptor-alpha mediates human T-cell activation and Th2 cytokine and chemokine production.
    BMC immunology, 2008, Apr-16, Volume: 9

    Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Benzoates; Cell Differentiation; Chromans; Cytokines; Dermatologic Agents; Fenretinide; Gene Expression Regulation; Humans; Lectins, C-Type; Lymphocyte Activation; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Tetrahydronaphthalenes; Th2 Cells; Tretinoin; Tumor Cells, Cultured

2008
chemdatabank.com